Business ❯Pharmaceutical Industry ❯Market Analysis

Sales Projections

Drug Pricing Consumer Demand Blenrep

UK Grants First Global Approval for GSK’s Blenrep in Two Combination Therapies

The MHRA authorizes Blenrep for relapsed or refractory multiple myeloma based on pivotal Phase 3 trial data, with reviews underway in 14 countries.

Weight Loss Industry Transformed by New Drugs and Emerging Alternatives